J&J Settles Risperdal Lawsuit for $7.8 Million

20.05.2015 - US pharmaceutical giant Johnson & Johnson has agreed to pay $7.8 million to settle a lawsuit over the marketing of its antipsychotic drug Risperdal to doctors in the US state of...